Filing Flows › Lucid Diagnostics (LUCD) › Q1 2025
Lucid Diagnostics (LUCD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 13, 2025
Lucid Diagnostics (LUCD) reported revenue of $828K for the first quarter 2025 (Q1 2025), -17% from a year earlier and -31% from the quarter before.
Lucid Diagnostics, Q1 2025: revenue $828K (-17% year over year), net loss $26.9M, operating cash flow −$12.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $828K | -31% | -17% |
| Operating profit | −$12.5M | — | — |
| Net earnings | −$26.9M | — | — |
| Operating cash flow | −$12.5M | — | — |
What changed
Revenue was $828K in Q1 2025, down 17% year over year and down 31% from the previous quarter.
Operating costs exceeded revenue by $12.5M, an operating margin of -1508.1%. Total costs grew 13% against a revenue fall of 17%. The fastest-growing cost line was General & admin (+51%). The quarter ended with a net loss of $26.9M, wider than the previous quarter's $11.5M loss. Net interest and other expense of $14.4M was the main reason.
Operating cash flow was −$12.5M. Non-cash charges added back $221K of depreciation and amortization and $949K of share-based compensation. Working capital and other items added $13.3M. Capital expenditures of $93K exceeded it, leaving free cash flow of −$12.6M.
Questions
What was Lucid Diagnostics' revenue in the first quarter 2025?
Lucid Diagnostics (LUCD) reported revenue of $828K for the first quarter 2025 (Q1 2025), -17% from a year earlier and -31% from the quarter before.
Source: Lucid Diagnostics 10-Q on SEC EDGAR.